[Critical evaluation of interaction screening software available in pharmacies].

Journal de pharmacie de Belgique Pub Date : 2012-12-01
S Schillemans, H De Loof, G R Y De Meyer
{"title":"[Critical evaluation of interaction screening software available in pharmacies].","authors":"S Schillemans,&nbsp;H De Loof,&nbsp;G R Y De Meyer","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Due to the increasing complexity of medication regimens it is not always easy for the pharmacist to quickly and effectively screen the drug use of a particular patient for interactions. By means of a survey and a comparison, the advantages and disadvantages of the most common software packages available in Flanders were analysed. Major stumbling blocks of the currently available software are the high number of false positive signals, the absence of a history regarding the management of interactions, the lack of timely updates of the database and the absence of clear guidelines for the management of an interaction. Based on this research, we make the following recommendations: (1) signal fatigue should be reduced by interaction screening based on the duration of therapy in addition to the ability to suppress signals, (2) a log, coupled with the prescription-register, should be implemented, (3) software companies should help pharmacists more in configuring software preferences and provide them with better information bout the available options, (4) the underlying databases must be updated more quickly. (5) OTC medications, especially in the context of polypharmacy, should be registered in the patient record by the pharmacist, (6) note that food supplements are not included in the interaction screening software, unlike registered medication. (7) the knowledge of pharmacists regarding interactions should be maintained and improved.</p>","PeriodicalId":14736,"journal":{"name":"Journal de pharmacie de Belgique","volume":" 4","pages":"4-13"},"PeriodicalIF":0.0000,"publicationDate":"2012-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal de pharmacie de Belgique","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Due to the increasing complexity of medication regimens it is not always easy for the pharmacist to quickly and effectively screen the drug use of a particular patient for interactions. By means of a survey and a comparison, the advantages and disadvantages of the most common software packages available in Flanders were analysed. Major stumbling blocks of the currently available software are the high number of false positive signals, the absence of a history regarding the management of interactions, the lack of timely updates of the database and the absence of clear guidelines for the management of an interaction. Based on this research, we make the following recommendations: (1) signal fatigue should be reduced by interaction screening based on the duration of therapy in addition to the ability to suppress signals, (2) a log, coupled with the prescription-register, should be implemented, (3) software companies should help pharmacists more in configuring software preferences and provide them with better information bout the available options, (4) the underlying databases must be updated more quickly. (5) OTC medications, especially in the context of polypharmacy, should be registered in the patient record by the pharmacist, (6) note that food supplements are not included in the interaction screening software, unlike registered medication. (7) the knowledge of pharmacists regarding interactions should be maintained and improved.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[对药店可用的相互作用筛选软件的关键评价]。
由于药物治疗方案的复杂性日益增加,药剂师要快速有效地筛选特定患者的药物使用情况并不总是容易的。通过调查和比较,分析了法兰德斯最常见的软件包的优缺点。目前可用的软件的主要障碍是大量的误报信号,缺乏关于交互管理的历史记录,缺乏数据库的及时更新以及缺乏交互管理的明确指导方针。在此基础上,我们提出以下建议:(1)除了抑制信号的能力外,还应通过基于治疗持续时间的交互筛选来减少信号疲劳;(2)应实施与处方注册相结合的日志;(3)软件公司应更多地帮助药剂师配置软件偏好,并为他们提供有关可用选项的更好信息;(4)底层数据库必须更快地更新。(5)非处方药,特别是在多种用药的情况下,应由药剂师在患者记录中登记;(6)注意,与注册药物不同,食品补充剂不包括在相互作用筛选软件中。(7)应保持和提高药师对相互作用的认识。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
[Hepatitis C]. [Essential oils: good advice by the pharmacist is necessary]. [Practical guidelines to ensure the quality of compounded preparations in community pharmacies]. [The social sciences at the Faculty of Pharmacy: and innovative course of community health at the University of Montreal]. [Pharmaceutical care for pediatric hemato-oncology and stem cell transplantation patients. Inventory of experiences and needs].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1